When a patient arrives with a sudden, severe headache, doctors need rapid, reliable tools to confirm or rule out a Subarachnoid Hemorrhage is bleeding into the space between the brain and its covering membranes, often caused by a ruptured aneurysm. The cornerstone of that decisionâmaking process is neuroimaging, a suite of techniques that let clinicians see inside the skull without surgery.
Subarachnoid hemorrhage (SAH) carries a mortality rate of 25â30 % within the first month, and half of survivors are left with lasting neurological deficits. Prompt detection enables:
Every minute counts, which is why emergency departments rely on fast, sensitive imaging.
A nonâcontrast CT Scan is computed tomography, an Xâray based technique that produces crossâsectional images of the brain in seconds. Its strengths for acute SAH include:
Modern 64âslice scanners can spot even 1 mm of blood, pushing sensitivity above 95 % in the first 12 hours. However, CTâs ability declines after 24 hours as clot density normalizes.
When CT results are equivocal or the bleed is delayed, a MRI is magnetic resonance imaging, which uses magnetic fields and radio waves to generate highâresolution images of soft tissue with sequences like FLAIR and T2* that highlight older blood products.
The tradeâoff is longer scan time (usually 20-30 minutes) and limited access in smaller centers.
Even the best nonâinvasive images can miss a tiny aneurysm. Digital Subtraction Angiography is an invasive Xâray procedure that injects contrast into cerebral vessels, producing dynamic, highâresolution vascular maps. DSA remains the gold standard for:
Because it carries a small risk of stroke (â0.5 %) and requires a specialized cath lab, DSA is typically reserved for cases where nonâinvasive imaging is inconclusive or when treatment is imminent.
Clinicians blend imaging findings with clinical scales to predict outcomes:
For example, a Fisher Grade 3 bleed (thick cisternal clot) combined with a HuntâHess Grade III patient signals a high risk of vasospasm, prompting early transcranial Doppler monitoring.
A typical SAH workâup looks like this:
This algorithm balances speed with diagnostic accuracy, ensuring patients get the right treatment at the right time.
Artificial intelligence algorithms are being trained on thousands of SAH cases to flag subtle blood on CT and suggest optimal vascular imaging pathways. Additionally, 7âTesla MRI promises even finer detection of microâhemorrhages and vessel wall inflammation, potentially identifying patients at risk before rupture.
While these technologies are still emerging, they hint at a future where neuroimaging not only diagnoses SAH faster but also predicts it.
Yes, especially if the scan is performed more than 24 hours after symptom onset. Blood density fades, making subtle hemorrhage hard to spot. In such cases, an MRI with FLAIR or a CTA is recommended.
MRI does not use ionizing radiation, so itâs safe for most patients. However, if a metallic implant is present, the scan may be contraindicated. The choice between MRI and CTA depends on availability and clinical urgency.
DSA is mandatory when nonâinvasive imaging fails to clearly identify the aneurysmâs size, neck, or exact location, or when immediate endovascular treatment is being considered.
Ideally within 24 hours of rupture. Early securing of the aneurysm (clipping or coiling) dramatically lowers reâbleeding risk and improves survival.
The Fisher Scale grades the amount of blood seen on CT, helping predict the likelihood of vasospasm. Higher grades (3â4) signal a need for aggressive monitoring and prophylactic therapy.
| Feature | CT Scan (Nonâcontrast) | MRI (FLAIR/SWI) | Digital Subtraction Angiography |
|---|---|---|---|
| Acute bleed detection | Excellent (90â95 % within 6 h) | Good, but slower | Gold standard for vascular detail |
| Time to result | 1â2 min | 20â30 min | 30â45 min (including prep) |
| Aneurysm size/neck visualization | Limited (requires CTA) | Moderate (highâres 3D MRI possible) | Highâresolution, 0.1 mm |
| Invasiveness | Nonâinvasive | Nonâinvasive | Invasive (catheter, contrast) |
| Complication risk | Radiation exposure | None (magnetic fields) | Stroke ~0.5 %, contrast nephropathy |
| Best use case | Initial assessment within hours of symptom onset | Late presentation or equivocal CT | Preâtreatment planning or when CTA is inconclusive |
Choosing the right modality hinges on timing, availability, and the clinical question at hand. In practice, most hospitals start with a rapid CT, then follow up with MRI or DSA as needed.
Benedict Posadas
Yo! CTs are the real MVP in SAH đ